Viewing Study NCT05274451

Bugs

Ignite Creation Date: 2025-12-24 @ 11:39 PM

Ignite Modification Date: 2026-06-01 @ 12:48 PM

Study NCT ID: NCT05274451

Status: TERMINATED

Last Update Posted: 2025-07-01

First Post: 2022-02-18

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: A Study to Investigate LYL797 in Adults With Solid Tumors

Sponsor: Lyell Immunopharma, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions:

Condition Brief	Condition Text	View

None	Triple Negative Breast Cancer	View
None	TNBC - Triple-Negative Breast Cancer	View
None	Non-small Cell Lung Cancer	View
None	Non Small Cell Lung Cancer	View
None	Non Small Cell Lung Cancer Metastatic	View
None	Non-Small Cell Carcinoma of Lung, TNM Stage 4	View
None	Advanced Breast Cancer	View
None	Advanced Lung Carcinoma	View
None	NSCLC	View
None	NSCLC, Recurrent	View
None	NSCLC Stage IV	View
None	Relapsed Cancer	View
None	Relapse/Recurrence	View
None	Recurrent Breast Cancer	View
None	Recurrent NSCLC	View
None	Platinum-resistant Ovarian Cancer	View
None	Ovarian Cancer	View
None	Primary Peritoneal Carcinoma	View
None	Fallopian Tube Cancer	View
None	Endometrial Cancer	View
None	Endometrioid Tumor	View
None	High Grade Serous Carcinoma	View
None	Ovarian Epithelial Cancer	View

Keywords:

Keyword Brief	Keyword Text	View

None	CAR T-cell therapy	View
None	CAR T	View
None	CAR T-cell	View
None	CAR-T	View
None	CAR-T cell therapy	View
None	CAR-T cell	View
None	ROR1	View
None	ROR1+	View
None	ROR1 positive	View
None	cell therapy	View
None	immunotherapy	View
None	relapsed	View
None	refractory	View
None	solid tumor	View
None	advanced	View
None	metastatic	View
None	breast cancer	View
None	lung cancer	View
None	triple negative breast cancer	View
None	non small cell lung cancer	View
None	ovarian cancer	View
None	endometrial cancer	View